Rockwell Medical Stock
Rockwell Medical, Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- CEO
- Mark Strobeck
- Employees
- 157
- Market cap
- $30 M
- IPO
- 27/01/1998
Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range of therapies and products aimed at addressing iron deficiency and supporting hemodialysis procedures, serving markets…
Rockwell Medical stock: price history
1D
-6.9%
1W
-5.8%
1M
-4.7%
6M
-18.7%
YTD
-10.9%
1Y
-37.6%
2Y
-79.0%
5Y
-88.7%
10Y
-98.8%
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~70% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 14/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Rockwell Medical
Analyst assessment of Rockwell Medical
PRICE TARGET LOW
US$20.00
CONSENSUS
US$20.00
MEDIAN
US$20.00
PRICE TARGET HIGH
US$20.00
0
STRONG BUY
10
BUY
2
HOLD
4
SELL
0
STRONG SELL
16
TOTAL · Buy
As of: 11/09/2026
Rockwell Medical stock metrics
P/E
-5.35
P/B
0.84
EV/EBITDA
-17.96
RETURN ON EQUITY
-3.3%
NET MARGIN
-6.6%
DEBT/EQUITY
0.4
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
89.0%
FLOAT SHARES
3,585,945
AVG. DAILY VOLUME (30D)
27,464
Insider transactions (SEC)
Strobeck Mark
Neri Jesse
TIMMINS MEGAN C.
Hunter Heather
Chole Timothy
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Rockwell Medical stock
What does Rockwell Medical do?
Rockwell Medical, Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.
The CEO is Mark Strobeck, the company employs around 157 people.
The IPO was on 27/01/1998; the stock trades on NASDAQ under the ticker RMTI.
What do analysts say about Rockwell Medical stock?
16 analysts rate the stock, the consensus is Buy (as of 11/09/2026).
The average price target is US$20.00, ranging from US$20.00 to US$20.00, with a median of US$20.00.
This is an external assessment, not a statement by Market Jury.
When does Rockwell Medical report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 70% stronger than usual.
Does Rockwell Medical pay a dividend?
No, Rockwell Medical currently does not pay a dividend.
Which stocks are comparable to Rockwell Medical?
Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Indivior Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences and Amphastar Pharmaceuticals.
How can I get Rockwell Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Rockwell Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.